Genomic profiling can help personalize cancer care, but patients may not be offered these tests due to a burdensome ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

Tempus AI is expanding its clinical oncology offering with the launch of ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer. ・The tool combines digital pathology and genomic ...

We retrospectively reviewed prostate cancer consults within one health care system from November 2, 2021, to January 2, 2023. We compared the proportion of patients who received genomic testing in the ...

Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...

On-site automated NGS using circulating tumor DNA enabled comprehensive genomic testing in ~27 hours, substantially shortening the interval between diagnosis and potential targeted-therapy selection.

An informational website and a mobile testing van in Philadelphia are making it easier to learn about cancer and get tested. Hall of Fame running back Emmitt Smith will be hosting a series of short ...